Dataset from A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006490
下载链接
链接失效反馈官方服务：
资源简介：
The study is designed to compare the effects of BI 409306 compared to placebo in patients
with cognitive impairment due to Alzheimer's Disease
创建时间：
2026-03-31
